Nuvectis Pharma Inc. (NVCT) Statistics & Valuation Metrics - Stocknear

Nuvectis Pharma Inc.

NASDAQ: NVCT · Real-Time Price · USD
5.95
-0.05 (-0.83%)
At close: Sep 24, 2025, 3:59 PM
5.95
0.00%
After-hours: Sep 24, 2025, 04:18 PM EDT

Nuvectis Pharma Statistics

Share Statistics

Nuvectis Pharma has 25.46M shares outstanding. The number of shares has increased by 12.01% in one year.

25.46M
12.01%
-10.68%
10.27%
14.54M
419
0.26%

Short Selling Information

The latest short interest is 982.84K, so 3.86% of the outstanding shares have been sold short.

982.84K
3.86%
6.4%
17.07

Valuation Ratios

The PE ratio is -4.87 and the forward PE ratio is -5.5. Nuvectis Pharma's PEG ratio is 0.22.

-4.87
-5.5
0
51.2
9.53
-7.56
0.22
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Nuvectis Pharma.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 2.09, with a Debt / Equity ratio of 0.

2.09
2.09
0
n/a
n/a
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1.46M
13
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -3.88% in the last 52 weeks. The beta is -0.28, so Nuvectis Pharma's price volatility has been lower than the market average.

-0.28
-3.88%
6.75
7.49
39.88
160,768

Income Statement

n/a
n/a
-19.85M
-19M
-19M
-19M
-1.11
Full Income Statement

Balance Sheet

The company has 18.53M in cash and 0 in debt, giving a net cash position of 18.53M.

18.53M
n/a
n/a
-73.25M
27.01M
16.87M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.25M and capital expenditures 0, giving a free cash flow of -12.25M.

-12.25M
n/a
-12.25M
-0.72
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

NVCT does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for NVCT is $17, which is 185.7% higher than the current price. The consensus rating is "Buy".

$17
185.7%
Buy
3
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

4.26
3